PHGDH and non-small cell lung carcinoma: In NSCLC, ubiquitination affects the sensitivity to gemcitabine treatment by mediating PHGDH protein homeostasis [45], suggesting that PHGDH ubiquitination is a potential target, which induces low protein expression and low nucleotide biosynthesis, thereby weakening the resistance to chemotherapeutic drugs targeting DNA.